Spero Therapeutics, Inc. (SPRO) stock
SPRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3045% below fair value
$0.90−0.05 (-4.77%)
Close on Nov 17, 2026Market cap $52.49MP/E 22.5Yield –
Spero Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Spero Therapeutics's market cap was $59.31M on Nov 11, 2026, against $135.15M a year earlier. Over the last 5 years it ranged from $23.98M to $515.85M, with a median of $77.64M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $59.31M | -54.8% |
| 2025 | Dec 31, 2025 | $131.21M | +134.5% |
| 2024 | Dec 31, 2024 | $55.94M | -28.2% |
| 2023 | Dec 29, 2023 | $77.91M | +5.1% |
| 2022 | Dec 30, 2022 | $74.14M | -85.6% |
| 2021 | Dec 31, 2021 | $515.85M | +2.4% |
| 2020 | Dec 31, 2020 | $503.56M | +180.6% |
| 2019 | Dec 31, 2019 | $179.45M | +60.5% |
| 2018 | Dec 31, 2018 | $111.82M | +2738.5% |
| 2017 | Dec 29, 2017 | $3.94M | – |
See a number that looks wrong?